XOMA Royalty Corporation Common Stock (XOMA) Stock Price

XOMAStock
$40.1738.70%52W
Market Cap$710.16M
P/E22.39x
PEG Ratio2.39
Div yield
Beta0.58

XOMA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)41.97%
Price vs S&P 500 (4W)-4.88%
PEG Ratio2.39
VGM Score43.69
P/E Ratio (Annual)22.39x

XOMA Earnings Surprise History

Q2 250.44est. -0.15
Q3 250.70est. -0.04
Q4 250.26est. -0.13

XOMA Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.80
3.89
3.89
3.89

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
XOMAXOMA Royalty Corporation Common Stock
DCC$40.17
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About XOMA Royalty Corporation Common Stock

XOMA Royalty Corp acquires future revenue rights from pre-commercial drug candidates licensed to pharmaceutical and biotechnology companies. This non-dilutive funding model enables biotech firms to advance their internal drug development without equity dilution. The company operates globally across the United States, Europe, Asia Pacific, and Switzerland.